Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Name | miRBASE accession |
---|---|
hsa-miR-200b-3p
|
MIMAT0000318 |
hsa-miR-200c-3p
|
MIMAT0000617 |
hsa-miR-429
|
MIMAT0001536 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_5632436 | 5.44 |
ENST00000340250.6
ENST00000382361.3 |
FSCN1
|
fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) |
chrX_+_64887512 | 5.12 |
ENST00000360270.5
|
MSN
|
moesin |
chr6_-_30654977 | 4.71 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
chr7_-_41742697 | 4.62 |
ENST00000242208.4
|
INHBA
|
inhibin, beta A |
chr10_+_102106829 | 4.62 |
ENST00000370355.2
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase) |
chr2_+_210444142 | 3.71 |
ENST00000360351.4
ENST00000361559.4 |
MAP2
|
microtubule-associated protein 2 |
chr13_-_30881621 | 3.22 |
ENST00000380615.3
|
KATNAL1
|
katanin p60 subunit A-like 1 |
chr9_+_34990219 | 3.22 |
ENST00000541010.1
ENST00000454002.2 ENST00000545841.1 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chr12_+_1800179 | 3.13 |
ENST00000357103.4
|
ADIPOR2
|
adiponectin receptor 2 |
chr7_+_36429409 | 3.12 |
ENST00000265748.2
|
ANLN
|
anillin, actin binding protein |
chr1_+_182992545 | 2.97 |
ENST00000258341.4
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2) |
chr21_-_16437255 | 2.94 |
ENST00000400199.1
ENST00000400202.1 |
NRIP1
|
nuclear receptor interacting protein 1 |
chr1_+_84543734 | 2.79 |
ENST00000370689.2
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr18_-_21166841 | 2.75 |
ENST00000269228.5
|
NPC1
|
Niemann-Pick disease, type C1 |
chr17_-_76870222 | 2.51 |
ENST00000585421.1
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
chr1_+_178694300 | 2.49 |
ENST00000367635.3
|
RALGPS2
|
Ral GEF with PH domain and SH3 binding motif 2 |
chr2_+_11886710 | 2.43 |
ENST00000256720.2
ENST00000441684.1 ENST00000423495.1 |
LPIN1
|
lipin 1 |
chr3_-_98620500 | 2.37 |
ENST00000326840.6
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2 |
chr5_-_112630598 | 2.27 |
ENST00000302475.4
|
MCC
|
mutated in colorectal cancers |
chr11_-_119599794 | 2.23 |
ENST00000264025.3
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
chr2_-_9143786 | 2.22 |
ENST00000462696.1
ENST00000305997.3 |
MBOAT2
|
membrane bound O-acyltransferase domain containing 2 |
chr7_-_28220354 | 2.20 |
ENST00000283928.5
|
JAZF1
|
JAZF zinc finger 1 |
chr1_+_201252580 | 2.20 |
ENST00000367324.3
ENST00000263946.3 |
PKP1
|
plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) |
chr14_-_35182994 | 2.15 |
ENST00000341223.3
|
CFL2
|
cofilin 2 (muscle) |
chr9_+_112810878 | 2.12 |
ENST00000434623.2
ENST00000374525.1 |
AKAP2
|
A kinase (PRKA) anchor protein 2 |
chr11_+_119076745 | 2.09 |
ENST00000264033.4
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase |
chr3_+_44379944 | 2.08 |
ENST00000396078.3
ENST00000342649.4 |
TCAIM
|
T cell activation inhibitor, mitochondrial |
chr9_+_132815985 | 2.04 |
ENST00000372410.3
|
GPR107
|
G protein-coupled receptor 107 |
chr2_+_102508955 | 2.00 |
ENST00000414004.2
|
FLJ20373
|
FLJ20373 |
chr9_+_112542572 | 1.98 |
ENST00000374530.3
|
PALM2-AKAP2
|
PALM2-AKAP2 readthrough |
chr22_+_21271714 | 1.92 |
ENST00000354336.3
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like |
chr3_-_52090461 | 1.89 |
ENST00000296483.6
ENST00000495880.1 |
DUSP7
|
dual specificity phosphatase 7 |
chr15_-_64673630 | 1.86 |
ENST00000558008.1
ENST00000559519.1 ENST00000380258.2 |
KIAA0101
|
KIAA0101 |
chr12_-_109125285 | 1.84 |
ENST00000552871.1
ENST00000261401.3 |
CORO1C
|
coronin, actin binding protein, 1C |
chr3_+_150126101 | 1.82 |
ENST00000361875.3
ENST00000361136.2 |
TSC22D2
|
TSC22 domain family, member 2 |
chr3_-_27498235 | 1.77 |
ENST00000295736.5
ENST00000428386.1 ENST00000428179.1 |
SLC4A7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7 |
chr5_+_38846101 | 1.74 |
ENST00000274276.3
|
OSMR
|
oncostatin M receptor |
chr6_-_31869769 | 1.73 |
ENST00000375527.2
|
ZBTB12
|
zinc finger and BTB domain containing 12 |
chr17_-_42908155 | 1.73 |
ENST00000426548.1
ENST00000590758.1 ENST00000591424.1 |
GJC1
|
gap junction protein, gamma 1, 45kDa |
chr6_+_43737939 | 1.71 |
ENST00000372067.3
|
VEGFA
|
vascular endothelial growth factor A |
chr21_-_15755446 | 1.70 |
ENST00000544452.1
ENST00000285667.3 |
HSPA13
|
heat shock protein 70kDa family, member 13 |
chr7_+_73703728 | 1.68 |
ENST00000361545.5
ENST00000223398.6 |
CLIP2
|
CAP-GLY domain containing linker protein 2 |
chr6_+_106546808 | 1.68 |
ENST00000369089.3
|
PRDM1
|
PR domain containing 1, with ZNF domain |
chr3_+_50192537 | 1.67 |
ENST00000002829.3
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr9_-_113800317 | 1.67 |
ENST00000374431.3
|
LPAR1
|
lysophosphatidic acid receptor 1 |
chr2_+_28615669 | 1.63 |
ENST00000379619.1
ENST00000264716.4 |
FOSL2
|
FOS-like antigen 2 |
chr8_+_22224811 | 1.62 |
ENST00000381237.1
|
SLC39A14
|
solute carrier family 39 (zinc transporter), member 14 |
chr5_+_174905398 | 1.61 |
ENST00000321442.5
|
SFXN1
|
sideroflexin 1 |
chr1_-_117210290 | 1.60 |
ENST00000369483.1
ENST00000369486.3 |
IGSF3
|
immunoglobulin superfamily, member 3 |
chr2_-_122407097 | 1.57 |
ENST00000409078.3
|
CLASP1
|
cytoplasmic linker associated protein 1 |
chr11_-_128392085 | 1.55 |
ENST00000526145.2
ENST00000531611.1 ENST00000319397.6 ENST00000345075.4 ENST00000535549.1 |
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
chr8_-_141645645 | 1.54 |
ENST00000519980.1
ENST00000220592.5 |
AGO2
|
argonaute RISC catalytic component 2 |
chr5_+_149887672 | 1.54 |
ENST00000261797.6
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
chr7_-_94285511 | 1.48 |
ENST00000265735.7
|
SGCE
|
sarcoglycan, epsilon |
chr1_+_25071848 | 1.47 |
ENST00000374379.4
|
CLIC4
|
chloride intracellular channel 4 |
chr1_+_110091189 | 1.45 |
ENST00000369851.4
|
GNAI3
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 |
chr12_-_52585765 | 1.44 |
ENST00000313234.5
ENST00000394815.2 |
KRT80
|
keratin 80 |
chr9_+_112403088 | 1.43 |
ENST00000448454.2
|
PALM2
|
paralemmin 2 |
chr19_-_11308190 | 1.41 |
ENST00000586659.1
ENST00000592903.1 ENST00000589359.1 ENST00000588724.1 ENST00000432929.2 |
KANK2
|
KN motif and ankyrin repeat domains 2 |
chr1_-_120190396 | 1.41 |
ENST00000421812.2
|
ZNF697
|
zinc finger protein 697 |
chr6_-_10415470 | 1.38 |
ENST00000379604.2
ENST00000379613.3 |
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chr1_-_208417620 | 1.36 |
ENST00000367033.3
|
PLXNA2
|
plexin A2 |
chr6_+_41040678 | 1.33 |
ENST00000341376.6
ENST00000353205.5 |
NFYA
|
nuclear transcription factor Y, alpha |
chr2_+_208576355 | 1.31 |
ENST00000420822.1
ENST00000295414.3 ENST00000339882.5 |
CCNYL1
|
cyclin Y-like 1 |
chr13_-_40177261 | 1.30 |
ENST00000379589.3
|
LHFP
|
lipoma HMGIC fusion partner |
chr9_+_128509624 | 1.30 |
ENST00000342287.5
ENST00000373487.4 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
chr1_-_231560790 | 1.30 |
ENST00000366641.3
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1 |
chr17_-_53499310 | 1.28 |
ENST00000262065.3
|
MMD
|
monocyte to macrophage differentiation-associated |
chr15_+_63481668 | 1.27 |
ENST00000321437.4
ENST00000559006.1 ENST00000448330.2 |
RAB8B
|
RAB8B, member RAS oncogene family |
chr3_-_185826855 | 1.27 |
ENST00000306376.5
|
ETV5
|
ets variant 5 |
chr1_+_230202936 | 1.27 |
ENST00000366672.4
|
GALNT2
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
chr6_+_114178512 | 1.26 |
ENST00000368635.4
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate |
chrX_-_131352152 | 1.26 |
ENST00000342983.2
|
RAP2C
|
RAP2C, member of RAS oncogene family |
chr19_-_40791302 | 1.26 |
ENST00000392038.2
ENST00000578123.1 |
AKT2
|
v-akt murine thymoma viral oncogene homolog 2 |
chr2_-_216300784 | 1.25 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
chrX_-_54522558 | 1.25 |
ENST00000375135.3
|
FGD1
|
FYVE, RhoGEF and PH domain containing 1 |
chr7_-_98741642 | 1.24 |
ENST00000361368.2
|
SMURF1
|
SMAD specific E3 ubiquitin protein ligase 1 |
chr9_-_139440314 | 1.23 |
ENST00000277541.6
|
NOTCH1
|
notch 1 |
chr1_-_28969517 | 1.21 |
ENST00000263974.4
ENST00000373824.4 |
TAF12
|
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa |
chr1_+_77333117 | 1.20 |
ENST00000477717.1
|
ST6GALNAC5
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 |
chr6_-_108395907 | 1.20 |
ENST00000193322.3
|
OSTM1
|
osteopetrosis associated transmembrane protein 1 |
chr22_-_50913371 | 1.20 |
ENST00000348911.6
ENST00000380817.3 ENST00000390679.3 |
SBF1
|
SET binding factor 1 |
chr9_+_2621798 | 1.19 |
ENST00000382100.3
|
VLDLR
|
very low density lipoprotein receptor |
chr11_-_46940074 | 1.19 |
ENST00000378623.1
ENST00000534404.1 |
LRP4
|
low density lipoprotein receptor-related protein 4 |
chr2_+_228336849 | 1.18 |
ENST00000409979.2
ENST00000310078.8 |
AGFG1
|
ArfGAP with FG repeats 1 |
chr12_+_120105558 | 1.15 |
ENST00000229328.5
ENST00000541640.1 |
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
chr10_+_120967072 | 1.14 |
ENST00000392870.2
|
GRK5
|
G protein-coupled receptor kinase 5 |
chr5_-_147162078 | 1.14 |
ENST00000507386.1
|
JAKMIP2
|
janus kinase and microtubule interacting protein 2 |
chr17_-_71640227 | 1.13 |
ENST00000388726.3
ENST00000392650.3 |
SDK2
|
sidekick cell adhesion molecule 2 |
chr9_-_136242909 | 1.13 |
ENST00000371991.3
ENST00000545297.1 |
SURF4
|
surfeit 4 |
chr3_-_69435224 | 1.13 |
ENST00000398540.3
|
FRMD4B
|
FERM domain containing 4B |
chr15_+_52121822 | 1.13 |
ENST00000558455.1
ENST00000308580.7 |
TMOD3
|
tropomodulin 3 (ubiquitous) |
chr11_+_94822968 | 1.12 |
ENST00000278505.4
|
ENDOD1
|
endonuclease domain containing 1 |
chr3_+_178866199 | 1.11 |
ENST00000263967.3
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
chr17_-_62658186 | 1.11 |
ENST00000262435.9
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2 |
chr22_-_36236265 | 1.10 |
ENST00000414461.2
ENST00000416721.2 ENST00000449924.2 ENST00000262829.7 ENST00000397305.3 |
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr1_-_225615599 | 1.10 |
ENST00000421383.1
ENST00000272163.4 |
LBR
|
lamin B receptor |
chr10_-_105615164 | 1.09 |
ENST00000355946.2
ENST00000369774.4 |
SH3PXD2A
|
SH3 and PX domains 2A |
chr9_+_131644388 | 1.09 |
ENST00000372600.4
|
LRRC8A
|
leucine rich repeat containing 8 family, member A |
chr16_+_8768422 | 1.08 |
ENST00000268251.8
ENST00000564714.1 |
ABAT
|
4-aminobutyrate aminotransferase |
chr2_-_166930131 | 1.08 |
ENST00000303395.4
ENST00000409050.1 ENST00000423058.2 ENST00000375405.3 |
SCN1A
|
sodium channel, voltage-gated, type I, alpha subunit |
chr1_-_78444776 | 1.07 |
ENST00000370767.1
ENST00000421641.1 |
FUBP1
|
far upstream element (FUSE) binding protein 1 |
chr12_-_106641728 | 1.07 |
ENST00000378026.4
|
CKAP4
|
cytoskeleton-associated protein 4 |
chr11_+_118477144 | 1.07 |
ENST00000361417.2
|
PHLDB1
|
pleckstrin homology-like domain, family B, member 1 |
chr9_-_110251836 | 1.07 |
ENST00000374672.4
|
KLF4
|
Kruppel-like factor 4 (gut) |
chr8_+_95653373 | 1.06 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
chr14_+_52118576 | 1.05 |
ENST00000395718.2
ENST00000344768.5 |
FRMD6
|
FERM domain containing 6 |
chr9_+_80912059 | 1.05 |
ENST00000347159.2
ENST00000376588.3 |
PSAT1
|
phosphoserine aminotransferase 1 |
chr17_-_49198216 | 1.03 |
ENST00000262013.7
ENST00000357122.4 |
SPAG9
|
sperm associated antigen 9 |
chr19_+_34287751 | 1.02 |
ENST00000590771.1
ENST00000589786.1 ENST00000284006.6 ENST00000588881.1 |
KCTD15
|
potassium channel tetramerization domain containing 15 |
chr17_-_79885576 | 1.02 |
ENST00000574686.1
ENST00000357736.4 |
MAFG
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G |
chr21_+_40177143 | 1.01 |
ENST00000360214.3
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
chr8_-_49833978 | 1.01 |
ENST00000020945.1
|
SNAI2
|
snail family zinc finger 2 |
chr3_-_138553594 | 1.01 |
ENST00000477593.1
ENST00000483968.1 |
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
chr2_+_201170703 | 0.99 |
ENST00000358677.5
|
SPATS2L
|
spermatogenesis associated, serine-rich 2-like |
chr15_-_49447835 | 0.95 |
ENST00000388901.5
ENST00000299259.6 |
COPS2
|
COP9 signalosome subunit 2 |
chr15_+_59063478 | 0.94 |
ENST00000559228.1
ENST00000450403.2 |
FAM63B
|
family with sequence similarity 63, member B |
chr1_-_8086343 | 0.93 |
ENST00000474874.1
ENST00000469499.1 ENST00000377482.5 |
ERRFI1
|
ERBB receptor feedback inhibitor 1 |
chr4_-_73434498 | 0.93 |
ENST00000286657.4
|
ADAMTS3
|
ADAM metallopeptidase with thrombospondin type 1 motif, 3 |
chr1_-_175161890 | 0.93 |
ENST00000545251.2
ENST00000423313.1 |
KIAA0040
|
KIAA0040 |
chr6_+_160390102 | 0.92 |
ENST00000356956.1
|
IGF2R
|
insulin-like growth factor 2 receptor |
chr4_-_122744998 | 0.92 |
ENST00000274026.5
|
CCNA2
|
cyclin A2 |
chr13_-_103451307 | 0.92 |
ENST00000376004.4
|
KDELC1
|
KDEL (Lys-Asp-Glu-Leu) containing 1 |
chr9_+_5629025 | 0.92 |
ENST00000251879.6
ENST00000414202.2 |
KIAA1432
|
KIAA1432 |
chr4_+_113066552 | 0.91 |
ENST00000309733.5
|
C4orf32
|
chromosome 4 open reading frame 32 |
chr9_-_34589700 | 0.90 |
ENST00000351266.4
|
CNTFR
|
ciliary neurotrophic factor receptor |
chr12_+_57522258 | 0.89 |
ENST00000553277.1
ENST00000243077.3 |
LRP1
|
low density lipoprotein receptor-related protein 1 |
chr3_-_176914238 | 0.89 |
ENST00000430069.1
ENST00000428970.1 |
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1 |
chr4_+_156588350 | 0.89 |
ENST00000296518.7
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr12_-_118797475 | 0.89 |
ENST00000541786.1
ENST00000419821.2 ENST00000541878.1 |
TAOK3
|
TAO kinase 3 |
chr5_+_14143728 | 0.89 |
ENST00000344204.4
ENST00000537187.1 |
TRIO
|
trio Rho guanine nucleotide exchange factor |
chr7_+_4721885 | 0.89 |
ENST00000328914.4
|
FOXK1
|
forkhead box K1 |
chr15_-_23932437 | 0.88 |
ENST00000331837.4
|
NDN
|
necdin, melanoma antigen (MAGE) family member |
chr12_+_97300995 | 0.87 |
ENST00000266742.4
ENST00000429527.2 ENST00000554226.1 ENST00000557478.1 ENST00000557092.1 ENST00000411739.2 ENST00000553609.1 |
NEDD1
|
neural precursor cell expressed, developmentally down-regulated 1 |
chr12_+_56325812 | 0.87 |
ENST00000394147.1
ENST00000551156.1 ENST00000553783.1 ENST00000557080.1 ENST00000432422.3 ENST00000556001.1 |
DGKA
|
diacylglycerol kinase, alpha 80kDa |
chr3_+_158991025 | 0.87 |
ENST00000337808.6
|
IQCJ-SCHIP1
|
IQCJ-SCHIP1 readthrough |
chr11_-_47788847 | 0.87 |
ENST00000263773.5
|
FNBP4
|
formin binding protein 4 |
chr13_-_21635631 | 0.86 |
ENST00000382592.4
|
LATS2
|
large tumor suppressor kinase 2 |
chrX_+_41192595 | 0.86 |
ENST00000399959.2
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked |
chr14_+_67826709 | 0.85 |
ENST00000256383.4
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa |
chr13_-_33859819 | 0.83 |
ENST00000336934.5
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13 |
chrX_+_150151752 | 0.83 |
ENST00000325307.7
|
HMGB3
|
high mobility group box 3 |
chr12_-_8025442 | 0.83 |
ENST00000340749.5
ENST00000535295.1 ENST00000539234.1 |
SLC2A14
|
solute carrier family 2 (facilitated glucose transporter), member 14 |
chr14_-_99737565 | 0.82 |
ENST00000357195.3
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein) |
chr12_-_8088871 | 0.82 |
ENST00000075120.7
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3 |
chr8_-_82024290 | 0.81 |
ENST00000220597.4
|
PAG1
|
phosphoprotein associated with glycosphingolipid microdomains 1 |
chr18_+_19321281 | 0.81 |
ENST00000261537.6
|
MIB1
|
mindbomb E3 ubiquitin protein ligase 1 |
chr21_+_39628655 | 0.81 |
ENST00000398925.1
ENST00000398928.1 ENST00000328656.4 ENST00000443341.1 |
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr3_+_141205852 | 0.80 |
ENST00000286364.3
ENST00000452898.1 |
RASA2
|
RAS p21 protein activator 2 |
chr12_-_28124903 | 0.80 |
ENST00000395872.1
ENST00000354417.3 ENST00000201015.4 |
PTHLH
|
parathyroid hormone-like hormone |
chr8_+_90769967 | 0.79 |
ENST00000220751.4
|
RIPK2
|
receptor-interacting serine-threonine kinase 2 |
chr7_+_77166592 | 0.78 |
ENST00000248594.6
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12 |
chr10_+_96162242 | 0.77 |
ENST00000225235.4
|
TBC1D12
|
TBC1 domain family, member 12 |
chr10_-_3827417 | 0.77 |
ENST00000497571.1
ENST00000542957.1 |
KLF6
|
Kruppel-like factor 6 |
chr3_+_159557637 | 0.77 |
ENST00000445224.2
|
SCHIP1
|
schwannomin interacting protein 1 |
chr5_+_70751442 | 0.77 |
ENST00000358731.4
ENST00000380675.2 |
BDP1
|
B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB |
chr11_-_64901978 | 0.76 |
ENST00000294256.8
ENST00000377190.3 |
SYVN1
|
synovial apoptosis inhibitor 1, synoviolin |
chr19_-_18632861 | 0.75 |
ENST00000262809.4
|
ELL
|
elongation factor RNA polymerase II |
chr4_-_68566832 | 0.75 |
ENST00000420827.2
ENST00000322244.5 |
UBA6
|
ubiquitin-like modifier activating enzyme 6 |
chr7_+_138916231 | 0.74 |
ENST00000473989.3
ENST00000288561.8 |
UBN2
|
ubinuclein 2 |
chr5_-_172198190 | 0.74 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
chr16_-_67281413 | 0.73 |
ENST00000258201.4
|
FHOD1
|
formin homology 2 domain containing 1 |
chr15_+_57884117 | 0.72 |
ENST00000267853.5
|
MYZAP
|
myocardial zonula adherens protein |
chr14_-_34931458 | 0.72 |
ENST00000298130.4
|
SPTSSA
|
serine palmitoyltransferase, small subunit A |
chr10_+_52751010 | 0.71 |
ENST00000373985.1
|
PRKG1
|
protein kinase, cGMP-dependent, type I |
chr19_+_797392 | 0.71 |
ENST00000350092.4
ENST00000349038.4 ENST00000586481.1 ENST00000585535.1 |
PTBP1
|
polypyrimidine tract binding protein 1 |
chr9_+_33817461 | 0.71 |
ENST00000263228.3
|
UBE2R2
|
ubiquitin-conjugating enzyme E2R 2 |
chr1_-_214724566 | 0.71 |
ENST00000366956.5
|
PTPN14
|
protein tyrosine phosphatase, non-receptor type 14 |
chr20_-_48729670 | 0.71 |
ENST00000371657.5
|
UBE2V1
|
ubiquitin-conjugating enzyme E2 variant 1 |
chr3_-_33686743 | 0.70 |
ENST00000333778.6
ENST00000539981.1 |
CLASP2
|
cytoplasmic linker associated protein 2 |
chr3_+_171758344 | 0.69 |
ENST00000336824.4
ENST00000423424.1 |
FNDC3B
|
fibronectin type III domain containing 3B |
chr8_+_8860314 | 0.69 |
ENST00000250263.7
ENST00000519292.1 |
ERI1
|
exoribonuclease 1 |
chr6_+_4890226 | 0.69 |
ENST00000343762.5
|
CDYL
|
chromodomain protein, Y-like |
chr7_-_27183263 | 0.69 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
chr17_-_63052929 | 0.68 |
ENST00000439174.2
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13 |
chr10_+_89622870 | 0.68 |
ENST00000371953.3
|
PTEN
|
phosphatase and tensin homolog |
chr7_-_111846435 | 0.68 |
ENST00000437633.1
ENST00000428084.1 |
DOCK4
|
dedicator of cytokinesis 4 |
chr8_+_104831472 | 0.67 |
ENST00000262231.10
ENST00000507740.1 |
RIMS2
|
regulating synaptic membrane exocytosis 2 |
chr3_-_120170052 | 0.67 |
ENST00000295633.3
|
FSTL1
|
follistatin-like 1 |
chr20_+_62795827 | 0.67 |
ENST00000328439.1
ENST00000536311.1 |
MYT1
|
myelin transcription factor 1 |
chr7_-_19748640 | 0.67 |
ENST00000222567.5
|
TWISTNB
|
TWIST neighbor |
chr4_-_176923483 | 0.67 |
ENST00000280187.7
ENST00000512509.1 |
GPM6A
|
glycoprotein M6A |
chr14_-_53417732 | 0.65 |
ENST00000399304.3
ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2
|
fermitin family member 2 |
chr10_-_23003460 | 0.65 |
ENST00000376573.4
|
PIP4K2A
|
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
chr1_+_40627038 | 0.64 |
ENST00000372771.4
|
RLF
|
rearranged L-myc fusion |
chr22_-_22307199 | 0.63 |
ENST00000397495.4
ENST00000263212.5 |
PPM1F
|
protein phosphatase, Mg2+/Mn2+ dependent, 1F |
chr3_-_123603137 | 0.63 |
ENST00000360304.3
ENST00000359169.1 ENST00000346322.5 ENST00000360772.3 |
MYLK
|
myosin light chain kinase |
chr10_-_120514720 | 0.63 |
ENST00000369151.3
ENST00000340214.4 |
CACUL1
|
CDK2-associated, cullin domain 1 |
chr16_-_70472946 | 0.62 |
ENST00000342907.2
|
ST3GAL2
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
chr17_-_48227877 | 0.62 |
ENST00000316878.6
|
PPP1R9B
|
protein phosphatase 1, regulatory subunit 9B |
chr14_+_55518349 | 0.62 |
ENST00000395468.4
|
MAPK1IP1L
|
mitogen-activated protein kinase 1 interacting protein 1-like |
chr11_+_128563652 | 0.62 |
ENST00000527786.2
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr1_+_28285973 | 0.62 |
ENST00000373884.5
|
XKR8
|
XK, Kell blood group complex subunit-related family, member 8 |
chr5_-_171433819 | 0.61 |
ENST00000296933.6
|
FBXW11
|
F-box and WD repeat domain containing 11 |
chr9_-_23821273 | 0.60 |
ENST00000380110.4
|
ELAVL2
|
ELAV like neuron-specific RNA binding protein 2 |
chr10_-_99052382 | 0.60 |
ENST00000453547.2
ENST00000316676.8 ENST00000358308.3 ENST00000466484.1 ENST00000358531.4 |
ARHGAP19-SLIT1
ARHGAP19
|
ARHGAP19-SLIT1 readthrough (NMD candidate) Rho GTPase activating protein 19 |
chr8_+_106330920 | 0.60 |
ENST00000407775.2
|
ZFPM2
|
zinc finger protein, FOG family member 2 |
chr10_+_60094735 | 0.59 |
ENST00000373910.4
|
UBE2D1
|
ubiquitin-conjugating enzyme E2D 1 |
chr17_+_57970469 | 0.59 |
ENST00000443572.2
ENST00000406116.3 ENST00000225577.4 ENST00000393021.3 |
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1 |
chr13_-_107187462 | 0.58 |
ENST00000245323.4
|
EFNB2
|
ephrin-B2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.6 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
1.5 | 4.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.0 | 3.1 | GO:1904172 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
0.9 | 5.4 | GO:0030035 | microspike assembly(GO:0030035) |
0.9 | 5.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.8 | 2.4 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.7 | 2.9 | GO:0003169 | coronary vein morphogenesis(GO:0003169) |
0.7 | 0.7 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.6 | 2.5 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.5 | 2.5 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.4 | 1.7 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.4 | 1.7 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.4 | 1.3 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.4 | 1.2 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.4 | 1.2 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.4 | 1.9 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
0.4 | 1.1 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.4 | 2.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.4 | 2.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 1.1 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
0.3 | 2.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 3.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 3.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 1.7 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
0.3 | 1.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 1.3 | GO:0071484 | response to high light intensity(GO:0009644) cellular response to light intensity(GO:0071484) |
0.3 | 0.9 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.3 | 2.1 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.3 | 1.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.3 | 0.6 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 0.3 | GO:0060458 | right lung development(GO:0060458) |
0.3 | 1.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 1.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.3 | 0.8 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.3 | 0.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.3 | 1.1 | GO:1904448 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.3 | 6.3 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.3 | 0.8 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.3 | 3.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.2 | 2.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.2 | 2.9 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 1.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.7 | GO:0060435 | bronchiole development(GO:0060435) |
0.2 | 0.9 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.2 | 1.5 | GO:0090625 | siRNA loading onto RISC involved in RNA interference(GO:0035087) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.2 | 1.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 1.3 | GO:0051344 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 1.3 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 0.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 1.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 0.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.2 | 1.6 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 2.8 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 1.1 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.2 | 0.5 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.2 | 2.0 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 0.9 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.2 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.2 | 1.1 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 1.0 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
0.2 | 0.9 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 0.9 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 1.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 0.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 1.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 0.5 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 1.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.2 | 0.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 0.8 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.2 | 0.3 | GO:0003285 | septum secundum development(GO:0003285) |
0.2 | 0.9 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.2 | 0.9 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 1.5 | GO:0015014 | protein sulfation(GO:0006477) heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.9 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.1 | 0.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 1.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.6 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 2.2 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.9 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 0.7 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.5 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.9 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.1 | 1.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 1.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.1 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
0.1 | 1.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 1.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 1.6 | GO:0015684 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.1 | 0.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.7 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.5 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.5 | GO:0048749 | compound eye development(GO:0048749) |
0.1 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 1.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.1 | 1.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.4 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.1 | 1.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.3 | GO:0061110 | histone H3-T6 phosphorylation(GO:0035408) dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 0.7 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.5 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.6 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 1.6 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.2 | GO:0035854 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
0.1 | 0.4 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.7 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.5 | GO:0035624 | receptor transactivation(GO:0035624) |
0.1 | 0.6 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.5 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 1.1 | GO:0035878 | nail development(GO:0035878) |
0.1 | 1.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.5 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.1 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.4 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.1 | 2.2 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.1 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.2 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.5 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.1 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.1 | 0.2 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.1 | 1.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 2.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 1.0 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.7 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 1.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.2 | GO:0046668 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) regulation of retinal cell programmed cell death(GO:0046668) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.1 | 0.2 | GO:0030860 | neuroblast division in subventricular zone(GO:0021849) regulation of polarized epithelial cell differentiation(GO:0030860) |
0.1 | 0.8 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 2.0 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.7 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 1.8 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.1 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.5 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.1 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.1 | 0.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 1.0 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.6 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.2 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.0 | 1.1 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 1.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.0 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 1.3 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.0 | 0.2 | GO:2000301 | negative regulation of long term synaptic depression(GO:1900453) regulation of intracellular transport of viral material(GO:1901252) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 1.7 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.0 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.3 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 1.1 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.1 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.8 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
0.0 | 0.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.1 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.0 | 0.9 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:1901355 | response to rapamycin(GO:1901355) |
0.0 | 0.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.8 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.9 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.2 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 2.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 1.5 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 1.8 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.3 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.4 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
0.0 | 0.6 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 2.4 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.0 | 0.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 2.2 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.2 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.0 | 1.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 1.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.0 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 1.3 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.0 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.2 | GO:1902746 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) regulation of lens fiber cell differentiation(GO:1902746) |
0.0 | 1.3 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.3 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.0 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.3 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.0 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.4 | GO:0006275 | regulation of DNA replication(GO:0006275) |
0.0 | 0.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.1 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.0 | 0.3 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.0 | 0.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.1 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.0 | 0.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.8 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:2001026 | regulation of endothelial cell chemotaxis(GO:2001026) positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.0 | 3.7 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.8 | GO:0001947 | heart looping(GO:0001947) |
0.0 | 0.1 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.0 | 0.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.1 | GO:0035547 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
0.0 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.8 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.0 | 0.8 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.3 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.4 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 1.1 | GO:0031100 | organ regeneration(GO:0031100) |
0.0 | 0.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.8 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 0.8 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 2.3 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 0.6 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 1.1 | GO:0032392 | DNA geometric change(GO:0032392) |
0.0 | 0.2 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.0 | 1.1 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.5 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.2 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.0 | 1.4 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.8 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.4 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.4 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.1 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.0 | 0.3 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.0 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.6 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
1.1 | 5.4 | GO:0044393 | microspike(GO:0044393) |
0.9 | 3.7 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.7 | 3.0 | GO:0043259 | laminin-1 complex(GO:0005606) laminin-10 complex(GO:0043259) laminin-11 complex(GO:0043260) |
0.6 | 3.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.6 | 1.7 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.5 | 1.4 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
0.4 | 5.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 5.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 1.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.3 | 0.9 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.3 | 0.8 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.3 | 1.1 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.3 | 0.8 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.2 | 1.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.1 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.2 | 3.3 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.8 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.2 | 1.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 1.3 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 2.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.7 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.1 | 1.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.4 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.1 | 1.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.6 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 0.5 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 2.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 1.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 1.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 1.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.5 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.5 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 0.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.9 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 1.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 1.7 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.4 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 1.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 1.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.3 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.5 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 1.2 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 2.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 1.0 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.7 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.0 | 1.5 | GO:1990752 | microtubule end(GO:1990752) |
0.0 | 0.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 1.2 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0044094 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
0.0 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 2.0 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.1 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 2.5 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 1.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 1.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 1.3 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 1.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 3.3 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 1.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 1.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 3.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 3.7 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 1.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 1.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 4.7 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.5 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 1.4 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.6 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.0 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) postsynaptic recycling endosome(GO:0098837) |
0.0 | 0.2 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.2 | GO:0001741 | XY body(GO:0001741) |
0.0 | 1.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.7 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 1.0 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.9 | 4.6 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.6 | 2.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.5 | 1.5 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.5 | 0.5 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.4 | 1.7 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.4 | 1.2 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.4 | 1.5 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.4 | 3.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 1.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.4 | 1.1 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.4 | 1.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 1.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 1.7 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.3 | 1.1 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.3 | 2.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 1.6 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 0.8 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.2 | 0.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 0.7 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.2 | 0.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 2.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.1 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.2 | 0.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 0.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 3.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 1.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 4.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 1.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 4.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 1.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 2.2 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.2 | 0.7 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.2 | 2.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 2.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 2.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.7 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 2.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 1.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 1.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 1.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 1.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 1.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.6 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 2.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 2.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.1 | 0.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.4 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 1.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 1.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 1.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 2.8 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 1.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 1.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.3 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.2 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.1 | 0.3 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 1.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.2 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.1 | 0.2 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.1 | 0.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 1.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 2.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 5.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.4 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 12.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 1.0 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.7 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 1.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.2 | GO:0015265 | urea channel activity(GO:0015265) |
0.0 | 1.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 5.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 1.0 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.2 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.0 | 0.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.8 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 3.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 6.3 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 2.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 1.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 1.6 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 1.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 1.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 1.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 1.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 1.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.7 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 1.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 1.5 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 1.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 1.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 1.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 4.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 2.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.5 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 0.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 9.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 2.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 3.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 2.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 5.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 3.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 3.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 2.9 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 3.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 1.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 5.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 1.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 4.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 2.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 1.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 2.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.1 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 1.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 2.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 1.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 3.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 4.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 1.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 6.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 4.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 2.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 2.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 4.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 3.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 3.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 3.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.2 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 1.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.5 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 1.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 2.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 2.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 1.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 1.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 1.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 1.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 2.5 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 1.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.8 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 1.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 1.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 1.8 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 1.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 1.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.5 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.4 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 0.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 1.1 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |